Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I-II, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of Technetium Tc99m Sestamibi in Pediatric Subjects

NCT00162045 is registered in ClinicalTrials.gov with Lantheus Medical Imaging as lead sponsor.

NCT NCT00162045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00162045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I-II, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of Technetium Tc99m Sestamibi in Pediatric Subjects
Lead sponsor
Lantheus Medical Imaging
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2005
Completion date
June 30, 2007
Enrollment
79 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

kawasaki disease